Post Elected to AAP
Dr. Wendy Post, professor in the Division of Cardiology, was elected into the Association of American Physicians (AAP) based on her accomplishments in translational biomedical… Read More »Post Elected to AAP
Medical Academic Skills Training Session
Click here to join via Zoom
Anti-TFAM antibodies link mitochondrial damage with antiphospholipid syndrome and thrombosis in SLE
ARTICLE: Anti-TFAM antibodies link mitochondrial damage with antiphospholipid syndrome and thrombosis in SLE AUTHORS: Eduardo Gómez-Bañuelos, Alessandra Ida Celia, Maria Isabel Trejo-Zambrano, Jesus Aureliano Robles-De Anda, Merlin Paz, Shruti Chaturvedi, Fabrizio… Read More »Anti-TFAM antibodies link mitochondrial damage with antiphospholipid syndrome and thrombosis in SLE
35th Annual Allergy and Clinical Immunology Fall Symposium
Please join us on Friday, November 21, 2025 at the Johns Hopkins Bayview Allergy and Asthma Center Auditorium for our Annual Allergy and Clinical Immunology… Read More »35th Annual Allergy and Clinical Immunology Fall Symposium
Mobile Hospice at JHH
The Johns Hopkins Hospital is partnering with Gilchrist to provide inpatient level hospice services to patients in the hospital setting who otherwise may not have… Read More »Mobile Hospice at JHH
Arwood Named Division Administrator of Gastroenterology & Hepatology
Ash Arwood has been named division administrator for the Division of Gastroenterology & Hepatology, effective September 15. Ash earned a Master of Business Administration from… Read More »Arwood Named Division Administrator of Gastroenterology & Hepatology
Simultaneous initiation of dolutegravir-based antiretroviral therapy and once-weekly rifapentine and isoniazid for tuberculosis prevention in antiretroviral-naive people with HIV: an open-label, non-randomised, phase 1/2 trial
ARTICLE: Simultaneous initiation of dolutegravir-based antiretroviral therapy and once-weekly rifapentine and isoniazid for tuberculosis prevention in antiretroviral-naive people with HIV: an open-label, non-randomised, phase 1/2… Read More »Simultaneous initiation of dolutegravir-based antiretroviral therapy and once-weekly rifapentine and isoniazid for tuberculosis prevention in antiretroviral-naive people with HIV: an open-label, non-randomised, phase 1/2 trial
Chaturvedi and Brodsky Receive $7.8M NIH Grant
Dr. Shruti Chaturvedi, associate professor in the Division of Hematology, and Dr. Robert Brodsky, professor and director of the Division of Hematology, are principal investigators on… Read More »Chaturvedi and Brodsky Receive $7.8M NIH Grant
